Literature DB >> 23074008

Obesity and PCOS: implications for diagnosis and treatment.

Richard S Legro1.   

Abstract

There appears to be an epidemic of both obesity and polycystic ovary syndrome (PCOS) in the world today. However, obesity per se is not a part of the phenotype in many parts of the world. Obesity is likely not a cause of PCOS, as the high prevalence of PCOS among relatively thin populations demonstrates. However, obesity does exacerbate many aspects of the phenotype, especially cardiovascular risk factors such as glucose intolerance and dyslipidemia. It is also associated with a poor response to infertility treatment and likely an increased risk for pregnancy complications in those women who do conceive. Although most treatments of obesity, with the exception of bariatric surgery, achieve modest reductions in weight and improvements in the PCOS phenotype, encouraging weight loss in the obese patient remains one of the front-line therapies. However, further studies are needed to identify the best treatments, and the role of lifestyle therapies in women of normal weight with PCOS is uncertain. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2012        PMID: 23074008      PMCID: PMC3649566          DOI: 10.1055/s-0032-1328878

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  81 in total

1.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

2.  Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.

Authors:  A Dunaif; D T Finegood
Journal:  J Clin Endocrinol Metab       Date:  1996-03       Impact factor: 5.958

3.  Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

Authors:  D A Ehrmann; R B Barnes; R L Rosenfield; M K Cavaghan; J Imperial
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

Review 4.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

5.  Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.

Authors:  B Imani; M J Eijkemans; E R te Velde; J D Habbema; B C Fauser
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

6.  Epithelial ovarian cancer risk among women with polycystic ovary syndrome.

Authors:  J M Schildkraut; P J Schwingl; E Bastos; A Evanoff; C Hughes
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

7.  Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.

Authors:  J E Nestler; D J Jakubowicz
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

8.  Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.

Authors:  E S Knochenhauer; T J Key; M Kahsar-Miller; W Waggoner; L R Boots; R Azziz
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

9.  Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor.

Authors:  D Willis; S Franks
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

10.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

Authors:  R S Legro; A R Kunselman; W C Dodson; A Dunaif
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

View more
  59 in total

1.  Adiponectin to the rescue: how the embryo maintains glucose uptake in a diabetic mother.

Authors:  Romana A Nowak
Journal:  Endocrinology       Date:  2013-07       Impact factor: 4.736

Review 2.  Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.

Authors:  A L L Rocha; L C Faria; T C M Guimarães; G V Moreira; A L Cândido; C A Couto; F M Reis
Journal:  J Endocrinol Invest       Date:  2017-06-13       Impact factor: 4.256

3.  The Impact of Bariatric Surgery Compared to Metformin Therapy on Pregnancy Outcomes in Patients with Polycystic Ovarian Syndrome: a Systematic Review and Meta-analysis.

Authors:  Catherine Chang; Steven Chang; Jillian Poles; Violeta Popov
Journal:  J Gastrointest Surg       Date:  2021-01-22       Impact factor: 3.452

4.  Waist-to-height ratio and BMI as predictive markers for insulin resistance in women with PCOS in Kolkata, India.

Authors:  Koushik Bhattacharya; Pallav Sengupta; Sulagna Dutta; Prasenjit Chaudhuri; Lipika Das Mukhopadhyay; Alak Kumar Syamal
Journal:  Endocrine       Date:  2021-01-05       Impact factor: 3.633

Review 5.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

Review 6.  Minireview: Metabolism of female reproduction: regulatory mechanisms and clinical implications.

Authors:  Emre Seli; Elnur Babayev; Stephen C Collins; Gabor Nemeth; Tamas L Horvath
Journal:  Mol Endocrinol       Date:  2014-03-28

7.  Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial.

Authors:  Ashraf Moini; Mahia Kanani; Ladan Kashani; Reihaneh Hosseini; Ladan Hosseini
Journal:  Endocrine       Date:  2014-10-08       Impact factor: 3.633

8.  The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study.

Authors:  D Romualdi; V Versace; V Tagliaferri; S De Cicco; V Immediata; R Apa; M Guido; A Lanzone
Journal:  J Endocrinol Invest       Date:  2019-03-07       Impact factor: 4.256

9.  Associations of childhood adiposity with menstrual irregularity and polycystic ovary syndrome in adulthood: the Childhood Determinants of Adult Health Study and the Bogalusa Heart Study.

Authors:  Y He; J Tian; L Blizzard; W H Oddy; T Dwyer; L A Bazzano; M Hickey; E W Harville; A J Venn
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

Review 10.  Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens.

Authors:  Licy L Yanes Cardozo; Damian G Romero; Jane F Reckelhoff
Journal:  Physiology (Bethesda)       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.